Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in the USA / NCT06742229
Starting soon Not applicable

Clinical Data Collection for Obstetric Ultrasound Algorithms

NCT06742229 · tracked via the Priya Life Science USA tracker
Sponsor
Caption Health, Inc
Phase
Not applicable
Started
2024-12-20
Last updated
2024-12-19

Condition(s) studied

Pregnancy

Investigational drug(s) / intervention(s)

Research Ultrasound scan

Research Ultrasound scan: Both the study groups will be asked to undergo a research scan performed by an FDA approved ultrasound device

Study summary

The goal of this clinical trial is to

* Collect ultrasound data from pregnant and non-pregnant individuals presenting to multiple study sites.
* Use the collected data and ultrasound images to train and validate Artificial intelligence algorithms developed by the Sponsor

Consented participants will be asked to take part in a research ultrasound scan

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Pregnant group (Group 1) 1. Participants aged 18 years or older at time of consent. 2. Participants with confirmed pregnancy (positive HCG urine test strip and/or a documented obstetric ultrasound scan. 3. Participants who are scheduled for or referred for a standard-of-care clinical obstetric ultrasound examination. 4. Participants who provide written consent. Non-pregnant group (Group 2) 1. Participants aged 18 years or older at time of consent. 2. Participants who are not actively pregnant (confirmed using an HCG urine test strip). 3. Participants who provide written informed consent. Exclusion Criteria: \- 1. Participants for whom participating in this study would delay or compromise care in any way. 2\. Participants who are not able to understand or provide written consent.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
University of Minnesota Minneapolis Minnesota
Baylor College of Medicine Houston Texas

More Caption Health, Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06742229 on ClinicalTrials.gov ↗ ← All trials in the USA